Emergency Use of IV Artesunate,
Role: PI,
Status: Approved
Federal
Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID),
Role: Investigator,
National Institute of Allergy and Infectious Diseases/NIH/DHHS,
Status: Completed
For Profit Organization
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection,
Role: Investigator,
Gilead Sciences, Inc,
(07/2024 - 07/2025)
Status: Approved
Internal
Outcome of ln Person Antimicrobial Stewardship Handshake Rounds at an Academic Medical Center,
Role: PI,
LLU Dept. of Medicine,
(05/2023)
Status: Approved